Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trial

Overview of attention for article published in Journal of Gastroenterology, August 2016

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 363 followers.

[VEGF] Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese s... https://t.co/lnuHDGLxWR PM

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.